Danazol in Refractory Autoimmune Hemolytic Anemia or Immune Thrombocytopenia: A Case Series Report and Literature Review

Danazol is a treatment option for autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Three patients with AIHA and eight patients with ITP between 2008 and 2022 were enrolled in the Rheumatology Outpatient Clinic of Chang Gung Memorial Hospital, Kaohsiung. Those patients were refra...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hsu-En, Lin, Ko-Ming, Lin, Jing-Chi, Lin, Yu-Ting, He, Hsiao-Ru, Wang, Yu-Wei, Yu, Shan-Fu, Chen, Jia-Feng, Cheng, Tien-Tsai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692819/
https://www.ncbi.nlm.nih.gov/pubmed/36355549
http://dx.doi.org/10.3390/ph15111377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692819/
https://www.ncbi.nlm.nih.gov/pubmed/36355549
http://dx.doi.org/10.3390/ph15111377

Ejemplares similares